Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal GLP-1 booster shows promise for weight loss and blood sugar in small trial

NCT ID NCT07141472

Disease control Sponsor: Lawry Han Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested a dietary supplement called GLP-1 Booster in 69 overweight adults over 26 weeks. The supplement contains extracts from green tea, gardenia, turmeric, and other herbs, and is designed to increase the body's own GLP-1 hormone to help control blood sugar, reduce appetite, and promote fat loss. Researchers measured changes in blood sugar, insulin, body weight, and body fat compared to a placebo.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GLP-1 Booster (a dietary supplement containing green tea, gardenia, turmeric, black pepper, fenugreek, ginseng, and white kidney bean extracts)
What this could lead to
If it works, this supplement could offer a natural way to help control blood sugar and support weight loss in overweight adults.
What could go wrong
This is a small, completed trial with only 69 participants, and dietary supplements often show limited or inconsistent effects. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

69 people

The number who actually took part.

Started

Jan 2025

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Volunteers must be over the age of 18. * Volunteers cannot be smokers. * Volunteers cannot be currently taking a dietary supplement or prescription for weight loss. * Exercising volunteers must maintain their regimen consistently throughout the course of the 26-week study. * Caffeine drinking volunteers must maintain their caffeine intake consistently throughout the course of the 26-week study. * Volunteers need to be overweight but not obese, as defined by having a BMI between 25.0 and 29.9

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood sugar; high are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hyperglycemia Insulin Resistance lipodystrophy Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood sugar; high Fat loss GLP - 1 Glucagon Overweight and obesity

Contacts and locations

Locations

  • Alpine Bio

    Salt Lake City, Utah, 84108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.